Last Updated : July 4, 2025
Details
| Call for patient/clinician input open | 05-Jun-24 |
|---|---|
| Call for patient/clinician input closed | 26-Jul-24 |
| Submission received | 16-Jul-24 |
| Submission accepted | 30-Jul-24 |
| Review initiated | 31-Jul-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 17-Oct-24 |
| Deadline for sponsors comments | 28-Oct-24 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 22-Nov-24 |
| Expert committee meeting (initial) | 04-Dec-24 |
| Draft recommendation issued to sponsor | 17-Dec-24 |
| Draft recommendation posted for stakeholder feedback | 02-Jan-25 |
| End of feedback period | 16-Jan-25 |
| Final recommendation issued to sponsor and drug plans | 31-Jan-25 |
| Final recommendation posted | 19-Feb-25 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 14-Feb-25 |
| CDA-AMC review report(s) posted | 08-May-25 |